New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice
(Q43454008)
scientific article published in January 1985
scientific article published in January 1985
Language:
Current Data About
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
69-75
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
1
|
||||||||||||||||
| (P478) |
15
|
||||||||||||||||
| (P577) |
Tuesday, January 1, 1985
|
||||||||||||||||
| (P921) |
(Q273510)
(Q323936)
|
||||||||||||||||
| (P1433) |
(Q6294770)
|
||||||||||||||||
| (P1476) |
"New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice" (language: en)
|
||||||||||||||||
| (P2093) |
Lefler E
Stevens DA
|
other details
| description | scientific article published in January 1985 |
External Links
| (P356) |
10.1093/JAC/15.1.69
|
| (P698) |
3972759
|